1. Dual silencing of EGFR and HER2 enhances the sensitivity of gastric cancer cells to gefitinib
   Liying Wang et al, 2018, Molecular Carcinogenesis CrossRef
2. The Novel Anti-cMet Antibody seeMet 12 Potentiates Sorafenib Therapy and Radiotherapy in a Colorectal Cancer Model
   Diana Spiegelberg et al, 2020, Frontiers in Oncology CrossRef